These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 2036386)

  • 1. Functional modulation of the isolated glycoprotein Ib binding domain of von Willebrand factor expressed in Escherichia coli.
    Sugimoto M; Ricca G; Hrinda ME; Schreiber AB; Searfoss GH; Bottini E; Ruggeri ZM
    Biochemistry; 1991 May; 30(21):5202-9. PubMed ID: 2036386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Purification of botrocetin from Bothrops jararaca venom. Analysis of the botrocetin-mediated interaction between von Willebrand factor and the human platelet membrane glycoprotein Ib-IX complex.
    Andrews RK; Booth WJ; Gorman JJ; Castaldi PA; Berndt MC
    Biochemistry; 1989 Oct; 28(21):8317-26. PubMed ID: 2557900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of discontinuous von Willebrand factor sequences involved in complex formation with botrocetin. A model for the regulation of von Willebrand factor binding to platelet glycoprotein Ib.
    Sugimoto M; Mohri H; McClintock RA; Ruggeri ZM
    J Biol Chem; 1991 Sep; 266(27):18172-8. PubMed ID: 1917949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of aspartic acid 514 through glutamic acid 542 as a glycoprotein Ib-IX complex receptor recognition sequence in von Willebrand factor. Mechanism of modulation of von Willebrand factor by ristocetin and botrocetin.
    Berndt MC; Ward CM; Booth WJ; Castaldi PA; Mazurov AV; Andrews RK
    Biochemistry; 1992 Nov; 31(45):11144-51. PubMed ID: 1359905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a point mutation in type IIB von Willebrand disease illustrating the regulation of von Willebrand factor affinity for the platelet membrane glycoprotein Ib-IX receptor.
    Ware J; Dent JA; Azuma H; Sugimoto M; Kyrle PA; Yoshioka A; Ruggeri ZM
    Proc Natl Acad Sci U S A; 1991 Apr; 88(7):2946-50. PubMed ID: 2011604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure and function of the von Willebrand factor A1 domain: analysis with monoclonal antibodies reveals distinct binding sites involved in recognition of the platelet membrane glycoprotein Ib-IX-V complex and ristocetin-dependent activation.
    De Luca M; Facey DA; Favaloro EJ; Hertzberg MS; Whisstock JC; McNally T; Andrews RK; Berndt MC
    Blood; 2000 Jan; 95(1):164-72. PubMed ID: 10607699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of structure-function relationships in the platelet membrane glycoprotein Ib-binding domain of von Willebrand's factor by expression of deletion mutants.
    Sugimoto M; Dent J; McClintock R; Ware J; Ruggeri ZM
    J Biol Chem; 1993 Jun; 268(16):12185-92. PubMed ID: 8505338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a site in the alpha chain of platelet glycoprotein Ib that participates in von Willebrand factor binding.
    Vicente V; Houghten RA; Ruggeri ZM
    J Biol Chem; 1990 Jan; 265(1):274-80. PubMed ID: 2104618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cross-linking of a monomeric 39/34-kDa dispase fragment of von Willebrand factor (Leu-480/Val-481-Gly-718) to the N-terminal region of the alpha-chain of membrane glycoprotein Ib on intact platelets with bis(sulfosuccinimidyl) suberate.
    Andrews RK; Gorman JJ; Booth WJ; Corino GL; Castaldi PA; Berndt MC
    Biochemistry; 1989 Oct; 28(21):8326-36. PubMed ID: 2690940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Site-directed mutagenesis of a soluble recombinant fragment of platelet glycoprotein Ib alpha demonstrating negatively charged residues involved in von Willebrand factor binding.
    Murata M; Ware J; Ruggeri ZM
    J Biol Chem; 1991 Aug; 266(23):15474-80. PubMed ID: 1651333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. von Willebrand disease type B: a missense mutation selectively abolishes ristocetin-induced von Willebrand factor binding to platelet glycoprotein Ib.
    Rabinowitz I; Tuley EA; Mancuso DJ; Randi AM; Firkin BG; Howard MA; Sadler JE
    Proc Natl Acad Sci U S A; 1992 Oct; 89(20):9846-9. PubMed ID: 1409710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolation of the von Willebrand factor domain interacting with platelet glycoprotein Ib, heparin, and collagen and characterization of its three distinct functional sites.
    Mohri H; Yoshioka A; Zimmerman TS; Ruggeri ZM
    J Biol Chem; 1989 Oct; 264(29):17361-7. PubMed ID: 2477370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of amino acid residues essential for von Willebrand factor binding to platelet glycoprotein Ib. Charged-to-alanine scanning mutagenesis of the A1 domain of human von Willebrand factor.
    Matsushita T; Sadler JE
    J Biol Chem; 1995 Jun; 270(22):13406-14. PubMed ID: 7539426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation and functional characterization of the von Willebrand factor-binding domain located between residues His1-Arg293 of the alpha-chain of glycoprotein Ib.
    Vicente V; Kostel PJ; Ruggeri ZM
    J Biol Chem; 1988 Dec; 263(34):18473-9. PubMed ID: 3263968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure and function of snake venom toxins interacting with human von Willebrand factor.
    Matsui T; Hamako J
    Toxicon; 2005 Jun; 45(8):1075-87. PubMed ID: 15922776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mocarhagin, a novel cobra venom metalloproteinase, cleaves the platelet von Willebrand factor receptor glycoprotein Ibalpha. Identification of the sulfated tyrosine/anionic sequence Tyr-276-Glu-282 of glycoprotein Ibalpha as a binding site for von Willebrand factor and alpha-thrombin.
    Ward CM; Andrews RK; Smith AI; Berndt MC
    Biochemistry; 1996 Apr; 35(15):4929-38. PubMed ID: 8664285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ristocetin and botrocetin involve two distinct domains of von Willebrand factor for binding to platelet membrane glycoprotein Ib.
    Girma JP; Takahashi Y; Yoshioka A; Diaz J; Meyer D
    Thromb Haemost; 1990 Oct; 64(2):326-32. PubMed ID: 1702906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced botrocetin-induced type IIB von Willebrand factor binding to platelet glycoprotein Ib initiates hyperagglutination of normal platelets.
    Nishio K; Fujimura Y; Niinomi K; Takahashi Y; Yoshioka A; Fukui H; Usami Y; Titani K; Ruggeri ZM; Zimmerman TS
    Am J Hematol; 1990 Apr; 33(4):261-6. PubMed ID: 2316510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinct abnormalities in the interaction of purified types IIA and IIB von Willebrand factor with the two platelet binding sites, glycoprotein complexes Ib-IX and IIb-IIIa.
    De Marco L; Mazzucato M; De Roia D; Casonato A; Federici AB; Girolami A; Ruggeri ZM
    J Clin Invest; 1990 Sep; 86(3):785-92. PubMed ID: 2394830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on anti-von Willebrand factor (vWF) monoclonal antibody NMC-4, which inhibits both ristocetin- and botrocetin-induced vWF binding to platelet glycoprotein Ib.
    Fujimura Y; Usami Y; Titani K; Niinomi K; Nishio K; Takase T; Yoshioka A; Fukui H
    Blood; 1991 Jan; 77(1):113-20. PubMed ID: 1984791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.